EMEA-000533-PIP01-08-M10

Invented name	Viread
Active substance	tenofovir disoproxil fumarate
Therapeutic area	Infectious diseases
Decision number	P/0156/2021
PIP number	EMEA-000533-PIP01-08-M10
Pharmaceutical form(s)	Film-coated tablet Granules
Condition(s) / indication(s)	Treatment of chronic viral hepatitis B Treatment of human immunodeficiency virus (HIV-1) infection
Route(s) of administration	Oral use
Contact for public enquiries	Gilead Sciences International Limited Tel. +44 (0)1223 897300 E-mail: regulatory.pip@gilead.com
Decision type	PM: decision on the application for modification of an agreed PIP

Add your rating

★ ★ ★ ★ ★